Over 40 Percent of Drivers with Past-Year Alcohol and Cannabis Use Report DUI

February 8, 2022

In a new study, researchers at Columbia University Mailman School of Public Health find that two in five drivers who report using alcohol and cannabis in the past year drove under the influence of alcohol, cannabis, or both. The findings are published in the American Journal of Preventive Medicine.

Earlier research suggested that simultaneous alcohol and cannabis use increases driving impairment, leading to an uptick in the risk of traffic fatality more than either substance individually, particularly among young adolescents. Yet, until now, no nationally representative study has tested the relationships between simultaneous use and driving under the influence of these substances.

“Alcohol and cannabis are two of the most common substances involved in impaired driving and motor vehicle crashes in the U.S.,” said Priscila Dib Gonçalves in the Department of Epidemiology at Columbia Mailman School, and first author. “Examining the effect of simultaneous alcohol and cannabis use on self-report driving under the influence of alcohol-only, cannabis-only, and both substances using a nationally representative sample could contribute to better understanding the impact in adolescents and adults.”

Drivers aged 16 years or older who reported any past-year alcohol and cannabis use in the National Survey on Drug Use and Health (2016-2019) were included with a final study sample of 34,514 individuals. The outcome was reporting any past-year driving under the influence of alcohol-only (DUI-A), cannabis-only (DUI-C), alcohol and cannabis (DUI-A+C), or no DUI. Data were further collected via face-to-face household interviews using computer-assisted interviewing and audio computer-assisted survey instruments to increase the accuracy of responses to potentially sensitive questions.

Between 2016-2019, 42 percent of drivers with past-year alcohol and cannabis use reported any past-year DUI (8 percent DUI-A, 20 percent DUI-C, 14 percent DUI-A+C). Simultaneous use was associated with 2.88 times higher odds of driving under the influence of cannabis, and 3.51 times higher odds of driving under the influence of both alcohol and cannabis.

Most participants were male (57 percent), non-Hispanic white (67 percent) with a family income of $40,000 or less (63 percent), and living in a state with medical cannabis laws (68 percent). Two-thirds of participants reported any tobacco use in the past year, and one-third used any drug other than cannabis. In addition, 8 percent reported daily alcohol use, 20 percent daily cannabis use, and 21 percent met criteria for alcohol use disorder, and 18 percent for cannabis use disorder. Over a quarter of the sample (28 percent) reported simultaneous alcohol/cannabis use. 

Daily alcohol and cannabis use increased the likelihood of DUI-A and DUI-C, respectively, and both alcohol/cannabis daily use was associated with DUI-A/C. “In the context of increasing daily cannabis use among adults, our findings connecting daily cannabis use and DUI raises public health concerns,” observed Pia Mauro, PhD, assistant professor of epidemiology, and senior author. “Population changes in cannabis use frequency that may be associated with health hazards, including daily use, need to be continuously monitored.”

“Our study is unique in that it reports more recent nationally representative data (2016-2019) and compares different types of DUI categories,” noted Gonçalves. “From a harm reduction perspective, identifying which population subgroups are at high risk for DUIs could assist the development of more focused prevention strategies. Future research should also investigate the potential impact of low or “promotional” cannabis prices with higher levels of use, intoxication, and simultaneous use of other substances.”

Co-authors are Sarah Gutkind, Luis Segura, João M. Castaldelli-Maia, and Silvia Martins, Columbia University Mailman School of Public Health. 

The study was funded by the National Institute on Drug Abuse (grants DA031099, DA037866, DA045224) and the National Center for Injury Prevention and Control (CE003094).